Viewing nowCombinationTelmisartan and Amlodipine Tablets 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Cejil Health Science Co., Ltd.

MFDS item code 201907043 · Approved 2019.10.04 · Insurance code 054301130
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively control blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with Amlodipine or Telmisartan.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the dose be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this medicine. However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This drug should not be used during pregnancy, especially in the second and third trimesters, as it can pose serious risks to the fetus. If pregnancy is confirmed, this medication should be discontinued as soon as possible. This drug is contraindicated in persons allergic to the active substance or any excipients, women who are pregnant or may become pregnant, nursing mothers, and patients with severe liver or biliary disease. Patients with significant heart problems or low blood pressure, and those in an unstable condition after acute myocardial infarction, should also not take this medication. Patients with certain heart diseases or liver function disorders, gastrointestinal diseases, renal vascular problems, those undergoing dialysis, and the elderly should use this drug with caution. While taking this medication, side effects such as dizziness or edema may occur, and serious side effects may infrequently arise, so caution is required. During treatment, blood pressure may drop too low, leading to issues such as hyperkalemia or renal function abnormalities; thus, regular monitoring is necessary. This medication may interact with other drugs, so it is important to inform healthcare professionals if you are taking other medications. Pregnant or nursing women should not take this medication, and if planning a pregnancy, it is advisable to switch to a safer antihypertensive drug. The safety and efficacy in children have not been established, so this drug is not recommended for them. In case of overdose, symptoms such as hypotension, dizziness, and cardiac arrhythmias may occur, requiring immediate medical attention. This medication should be kept out of reach of children, and it is important to store it sealed until just prior to administration.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a tightly closed container that blocks light. It is advisable to store it at room temperature between 1 to 30 degrees Celsius to maintain its efficacy and safety.
White oval biconvex tablet
30 tablets (10 tablets/PTP X 3), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Cejil Health Science Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.